Brain Organoid Therapeutics (bot)

Brain Organoid Therapeutics (BOT) is a screening platform that leverages innovative human neural models in vitro to evaluate the efficacy and neurotoxicity of agents and therapeutics interacting with the nervous system. 

Our expert team employs rigorous, state-of-the-art research methods to develop electrophysiologically-relevant neural models that closely mimic the human nervous system. Focused on scientific excellence and patient well-being, we collaborate with industry and academic researchers to provide our services and accelerate the translation of therapeutic breakthroughs while minimising neurotoxicity risks.

BOT operates under Flinders University and is located at the South Australia Health and Medical Research Centre (SAHMRI).